Polatuzumab works by binding with cancer cells and releasing a chemical called monomethyl auristatin E, into the cell causing the cancer cells to die or stop growing.
Common side effects of Polatuzumab
Peripheral neuropathy (tingling and numbness of feet and hand), Nausea, Fatigue, Diarrhea, Constipation, Hair loss, Mucositis, Lymphopenia, Decreased white blood cell count (neutrophils), Increased uric acid level in blood, Anemia (low number of red blood cells), Low blood platelets, Fever, Decreased appetite, Pneumonia
Reviewed By Dr. Rajeev Sharma